---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-007528"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T02:15:12.494612+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health reports H1 2023 adjusted net income $3.01M, issues 2026 guidance of $180M revenue

## Summary
- H1 2023 Adjusted EBITDA of $3.01M (up 182% YoY) and Adjusted Net Income of $3.01M (up from -$0.09M loss).
- Inaugural 2026 guidance: gross annual revenue exceeding $180M and EBITDA >$20M.
- Completed three acquisitions in 2023: Cana Laboratories, Bikas GP (adds >$10M annual revenue), and ZipDoctor.
- Book value per share >$4 (2.5x current price); unencumbered properties fair value >$12M (>50% market cap).
- CEO Greg Siokas invested >$15M total, ~$850K YTD; share buyback up to $3M started Sept 13.

## SEC filing metadata
- accession: 0001477932-23-007528
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/0001477932-23-007528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-007528
- JSON: https://secwatch.observer/filing/0001477932-23-007528.json
- Plain text: https://secwatch.observer/filing/0001477932-23-007528.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.